Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis

Area of Science:

• Pulmonary Medicine
• Infectious Diseases
• Microbiology

Background:

• Cystic fibrosis (CF) involves impaired airway clearance, predisposing individuals to chronic bacterial infections, notably Pseudomonas aeruginosa.
• P. aeruginosa infections in CF are unique, affecting immunocompetent hosts with compromised airway clearance mechanisms.
• The P. aeruginosa clone acquired by CF patients often persists for years, undergoing diversification through mutations and accessory genome changes.

Purpose of the Study:

• To explore the unique characteristics of P. aeruginosa airway infections in cystic fibrosis patients.
• To understand the dynamics of P. aeruginosa colonization, diversification, and transmission within the CF population.
• To evaluate the impact of early antipseudomonal chemotherapy on P. aeruginosa colonization onset and identify persistent challenges.

Main Methods:

• Review of existing literature on P. aeruginosa infections in cystic fibrosis.
• Analysis of P. aeruginosa clone persistence, diversification mechanisms (point mutations, accessory genome).
• Examination of co-colonization patterns and the role of sinuses as a reservoir.

Main Results:

• P. aeruginosa clones can persist for many years, diversifying over time.
• Co-colonization with multiple clones is common in the initial three years.
• Sinuses appear to serve as a reservoir for lower airway colonization.
• Early antipseudomonal chemotherapy achieves an 80% eradication rate, delaying chronic colonization onset to early adulthood.
• Significant improvements in prevention and treatment over the last two decades.

Conclusions:

• Early eradication of P. aeruginosa is crucial for managing CF airway infections.
• While treatment has improved, highly transmissible epidemic strains pose an ongoing threat.
• Further research is needed to address the challenge of epidemic P. aeruginosa strains in the CF community.